Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.

Dawson MI, Xia Z, Liu G, Ye M, Fontana JA, Farhana L, Patel BB, Arumugarajah S, Bhuiyan M, Zhang XK, Han YH, Stallcup WB, Fukushi J, Mustelin T, Tautz L, Su Y, Harris DL, Waleh N, Hobbs PD, Jong L, Chao WR, Schiff LJ, Sani BP.

J Med Chem. 2007 May 31;50(11):2622-39. Epub 2007 May 10. Erratum in: J Med Chem. 2008 Oct 9;51(19):6236. Ye, Mao [added].

3.

Cellular and pharmacological bases of the antitumor activity of a novel adamantyl retinoid, ST1926.

Pisano C, Merlini L, Penco S, Carminati P, Zunino F.

J Chemother. 2004 Nov;16 Suppl 4:74-6. Review.

PMID:
15688616
4.

Receptor-independent induction of apoptosis by synthetic retinoids.

Lotan R.

J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):13-28. Review.

PMID:
12757019
5.

Targeting Nur77 translocation.

Zhang XK.

Expert Opin Ther Targets. 2007 Jan;11(1):69-79. Review.

PMID:
17150035
6.

Classical and novel retinoids: their targets in cancer therapy.

Fontana JA, Rishi AK.

Leukemia. 2002 Apr;16(4):463-72. Review.

Supplemental Content

Support Center